BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 30942427)

  • 1. CBX3 predicts an unfavorable prognosis and promotes tumorigenesis in osteosarcoma.
    Ma C; Nie XG; Wang YL; Liu XH; Liang X; Zhou QL; Wu DP
    Mol Med Rep; 2019 May; 19(5):4205-4212. PubMed ID: 30942427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CBX3 promotes glioma U87 cell proliferation and predicts an unfavorable prognosis.
    Zhao SP; Wang F; Yang M; Wang XY; Jin CL; Ji QK; Li S; Zhao XL
    J Neurooncol; 2019 Oct; 145(1):35-48. PubMed ID: 31502042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CBX3 promotes tumor proliferation by regulating G1/S phase via p21 downregulation and associates with poor prognosis in tongue squamous cell carcinoma.
    Zhang H; Chen W; Fu X; Su X; Yang A
    Gene; 2018 May; 654():49-56. PubMed ID: 29462646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TopBP1 promotes malignant progression and correlates with poor prognosis in osteosarcoma.
    Wu DP; Yan XB; Liu LG; Tian C; Han K; Zhang H; Min DL
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4022-4031. PubMed ID: 29028101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased microRNA-452 expression and its prognostic significance in human osteosarcoma.
    Li RZ; Wang LM
    World J Surg Oncol; 2016 May; 14():150. PubMed ID: 27193084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CUL4A expression in pediatric osteosarcoma tissues and its effect on cell growth in osteosarcoma cells.
    Li X; Xu R; Liu H; Fang K
    Tumour Biol; 2016 Jun; 37(6):8139-44. PubMed ID: 26715273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.
    Zhu B; Cheng D; Li S; Zhou S; Yang Q
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA‑106a regulates the proliferation and invasion of human osteosarcoma cells by targeting VNN2.
    Chen Y; Huang T; Yang X; Liu C; Li P; Wang Z; Zhi S
    Oncol Rep; 2018 Oct; 40(4):2251-2259. PubMed ID: 30066949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of X-Box Binding Protein 1 (XBP1) Correlates to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human Osteosarcoma.
    Yang J; Cheng D; Zhou S; Zhu B; Hu T; Yang Q
    Int J Mol Sci; 2015 Dec; 16(12):28635-46. PubMed ID: 26633383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.
    Yu W; Zhang Z; Min D; Yang Q; Du X; Tang L; Lin F; Sun Y; Zhao H; Zheng S; He A; Li H; Yao Y; Shen Z
    Eur J Cancer; 2014 Apr; 50(6):1125-36. PubMed ID: 24565852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Expression of microRNA-199b-5p Associates with Poor Prognosis Through Promoting Cell Proliferation, Invasion and Migration Abilities of Human Osteosarcoma.
    Zeng H; Zhang Z; Dai X; Chen Y; Ye J; Jin Z
    Pathol Oncol Res; 2016 Apr; 22(2):253-60. PubMed ID: 26183062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-21 predicts poor prognosis in patients with osteosarcoma.
    Ren X; Shen Y; Zheng S; Liu J; Jiang X
    Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
    Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
    Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CBX3 promotes breast cancer progression and high level of CBX3 predicts poor prognosis in patients.
    Yang K; Wang YL; Zhu Z; Cao XH; Liang MX; Xu D; Fei YJ; Yang SY; Zhou HL; Tang JH
    Neoplasma; 2023 Feb; 70(1):71-81. PubMed ID: 36620876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation and biological function of transmembrane protein 119 in osteosarcoma.
    Jiang ZH; Peng J; Yang HL; Fu XL; Wang JZ; Liu L; Jiang JN; Tan YF; Ge ZJ
    Exp Mol Med; 2017 May; 49(5):e329. PubMed ID: 28496199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GDF15 promotes osteosarcoma cell migration and invasion by regulating the TGF‑β signaling pathway.
    Chen G; Wang M; Liu X
    Mol Med Rep; 2019 Nov; 20(5):4262-4270. PubMed ID: 31545486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9.
    Zhang G; Li M; Jin J; Bai Y; Yang C
    Asian Pac J Cancer Prev; 2011; 12(8):2075-80. PubMed ID: 22292654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid receptor DNA binding factor 1 expression and osteosarcoma prognosis.
    Zhao J; Xu H; He M; Wu Y
    Tumour Biol; 2014 Dec; 35(12):12449-58. PubMed ID: 25185653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal adhesion kinase overexpression and its impact on human osteosarcoma.
    Ren K; Lu X; Yao N; Chen Y; Yang A; Chen H; Zhang J; Wu S; Shi X; Wang C; Sun X
    Oncotarget; 2015 Oct; 6(31):31085-103. PubMed ID: 26393679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of MSH6 gene silencing in combination with cisplatin on cell proliferation of human osteosarcoma cell line MG63.
    Liu HC; Zeng J; Zhang B; Liu XQ; Dai M
    J Cell Physiol; 2019 Jun; 234(6):9358-9369. PubMed ID: 30456894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.